Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology

Currently, oncology testing includes molecular studies and cytogenetic analysis to detect genetic aberrations of clinical significance. Next-generation sequencing (NGS) allows rapid analysis of multiple genes for clinically actionable somatic variants. The WUCaMP assay uses targeted capture for NGS...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Mol Diagn
Auteurs principaux: Cottrell, Catherine E., Al-Kateb, Hussam, Bredemeyer, Andrew J., Duncavage, Eric J., Spencer, David H., Abel, Haley J., Lockwood, Christina M., Hagemann, Ian S., O’Guin, Stephanie M., Burcea, Lauren C., Sawyer, Christopher S., Oschwald, Dayna M., Stratman, Jennifer L., Sher, Dorie A., Johnson, Mark R., Brown, Justin T., Cliften, Paul F., George, Bijoy, McIntosh, Leslie D., Shrivastava, Savita, Nguyen, TuDung T., Payton, Jacqueline E., Watson, Mark A., Crosby, Seth D., Head, Richard D., Mitra, Robi D., Nagarajan, Rakesh, Kulkarni, Shashikant, Seibert, Karen, Virgin, Herbert W., Milbrandt, Jeffrey, Pfeifer, John D.
Format: Artigo
Langue:Inglês
Publié: American Society for Investigative Pathology 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762937/
https://ncbi.nlm.nih.gov/pubmed/24211365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2013.10.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires